Poltreg (WAR:PTG) ROCE %: -44.40% (As of Mar. 2026)


WAR:PTG Poltreg SA WAR:PTG
46 GF Score
Price zł19.15
GF Value zł14.20
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Poltreg ROCE %?

Poltreg WAR:PTG +1.86% 46 ROCE % is -44.40% as of Mar. 2026. GuruFocus rates WAR:PTG with a GF Score™ of 46/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Poltreg's annualized ROCE % for the quarter that ended in Mar. 2026 was -44.40%.

Poltreg  (WAR:PTG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Poltreg ROCE % Related Terms

Poltreg ROCE % Historical Data

* Premium members only.

The historical data trend for Poltreg's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poltreg ROCE % Chart

Poltreg Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -6.34 -1.58 -11.66 -17.92 -32.77

Poltreg Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.94 -41.29 -32.39 -34.80 -44.40
WAR:PTG
46GF Score
Poltreg SA WAR:PTG
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poltreg ROCE % Calculation

Poltreg's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-25.196/( ( (102.379 - 11.476) + (72.958 - 10.088) )/ 2 )
=-25.196/( (90.903+62.87)/ 2 )
=-25.196/76.8865
=-32.77 %

Poltreg's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-26.316/( ( (72.958 - 10.088) + (65.032 - 9.357) )/ 2 )
=-26.316/( ( 62.87 + 55.675 )/ 2 )
=-26.316/59.2725
=-44.40 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -44.40% mean?
Poltreg (WAR:PTG) has a ROCE % of -44.40% as of Mar. 2026.
Is Poltreg's ROCE % too high?
Poltreg's current ROCE % is -44.40%. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's ROCE % compare to VRTX and REGN?
Poltreg's ROCE % of -44.40% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Poltreg's current ROCE % is -44.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł19.15 — trading 34.9% above its estimated fair value. The current ROCE % is -44.40%. Poltreg's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current ROCE % is -44.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Poltreg (WAR:PTG) Overvalued in 2026?

Based on GuruFocus' analysis, Poltreg stock appears to be overvalued. The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20. GuruFocus considers Poltreg to be Significantly Overvalued.

Key valuation signals for WAR:PTG:

  • ROCE %: -44.40%
  • GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poltreg Business Description

Address ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score

Get the complete analysis for WAR:PTG

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł19.15
Price
zł14.20
GF Value